Corcept Therapeutics
CORT
#2078
Rank
NZ$15.70 B
Marketcap
NZ$149.05
Share price
1.71%
Change (1 day)
47.55%
Change (1 year)

Corcept Therapeutics (CORT) - Cash on Hand

Cash on Hand as of September 2025 : NZ$0.72 Billion

According to Corcept Therapeutics 's latest financial reports the company has NZ$0.72 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Corcept Therapeutics - Cash on Hand chart (from 2003 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31NZ$0.67 B16.74%
2023-12-31NZ$0.58 B-14.36%
2022-12-31NZ$0.67 B107.75%
2021-12-31NZ$0.32 B-46.42%
2020-12-31NZ$0.61 B49.06%
2019-12-31NZ$0.40 B32.93%
2018-12-31NZ$0.30 B146.68%
2017-12-31NZ$0.12 B67.95%
2016-12-31NZ$74.39 M25.93%
2015-12-31NZ$59.07 M90.9%
2014-12-31NZ$30.94 M-53.66%
2013-12-31NZ$66.77 M-40.95%
2012-12-31NZ$0.11 B122.69%
2011-12-31NZ$50.78 M59.41%
2010-12-31NZ$31.85 M-3.05%
2009-12-31NZ$32.86 M4.15%
2008-12-31NZ$31.55 M39.16%
2007-12-31NZ$22.67 M68.91%
2006-12-31NZ$13.42 M-68.45%
2005-12-31NZ$42.54 M-18.83%
2004-12-31NZ$52.41 M194.31%
2003-12-31NZ$17.8 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
NZ$32.13 B 4,301.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$28.56 B 3,813.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$16.88 B 2,212.87%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
NZ$17.16 B 2,250.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$25.93 B 3,453.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$31.52 B 4,219.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
NZ$0.16 B-78.08%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
NZ$0.45 B-38.33%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$2.55 B 250.46%๐Ÿ‡บ๐Ÿ‡ธ USA